Given the prominent role of Notch1 and Notch3 signaling in physiological development of many tissues and in pathogenesis, chemo-resistance and relapse of different human cancers, including T-ALL, many efforts have been paid to unveil molecular mechanisms priming their activation or sustaining the strength and the activity of their signaling (1). This evidence concerns the gene NOTCH3 and acute lymphoblastic leukemia.